Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR Research Protocols (no longer under consideration since Oct 06, 2018)

Date Submitted: Sep 26, 2017
Open Peer Review Period: Sep 28, 2017 - Oct 12, 2017
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

The development of an iPad based App to support clinical and research assessment of cognition in dementia: ACEmobile.

  • Craig Newman; 
  • John Hodges; 
  • John Zajicek; 
  • Rupert Noad

Background:

Cognitive screening is common practice in efforts to identify Alzheimer’s dementia in the early stages. The need for reliable and accurate assessment is critical, at this stage, to avoid distress or missed opportunities to support people with developing health needs. Administrator errors are observed to be both significant and common when clinicians deliver cognitive screening tools in clinical contexts, often as a result of complicated rules and the need for mental arithmetic. The Addenbrooke’s Cognitive Examination-III is one of the most used cognitive screening tools in the UK, observed to be prone to such user errors.

Objective:

We aimed to develop and release a computerized cognitive screening support tool for clinicians who use the Addenbrooke’s Cognitive Examination-III to screen for dementia.

Methods:

We undertook an innovation pathways approach, including problem identification, feasibility assessment, design and implementation. This project required numerous stages of consideration to meet data protection and NHS standards for implementation, this process is detailed.

Results:

Clinicians were provided an iPad based app (ACEmobile) via iTunes, which draws on usability research to standardize user behavior – thus standardizing the assessment of cognitive impairment alongside automated scoring. Results include continued use after three years in the market, registration from over 1,100 clinical users and the consented collection of over 4,300 dementia assessments to support further research into the development of ACE-III and ACEmobile.

Conclusions:

ACEmobile has demonstrated itself as a clinical tool which continues to support a large number of clinicians and large scale research projects. The focus on usability has added value to its predecessor (ACE-III) in that the clinician’s assessment is now supported to be standardized. Feedback relating to ACEmobile has been unanimously positive and reflects these strengths.


 Citation

Please cite as:

Newman C, Hodges J, Zajicek J, Noad R

The development of an iPad based App to support clinical and research assessment of cognition in dementia: ACEmobile.

JMIR Preprints. 26/09/2017:9047

DOI: 10.2196/preprints.9047

URL: https://preprints.jmir.org/preprint/9047

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.